Immune Checkpoint Inhibitor in Advanced TNBC

Download these slides from our 2020 ASCO TNBC webinar on the latest advances of immune checkpoint inhibitors in advanced triple-negative breast cancer.
Rita Nanda, MD
Format: Microsoft PowerPoint (.ppt)
File Size: 1.00 MB
Released: June 30, 2020

Acknowledgements

Provided by Clinical Care Options, LLC.

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by an educational grant from
Genentech, a member of the Roche Group

Related Content

In this video from Clinical Care Options (CCO), Drs Michael Bishop, Jesús Berdeja, and Jae Park discuss key data on CAR T-cell therapy

Michael R. Bishop, MD
Program Director
person default Jesús G. Berdeja, MD Jae H. Park, MD
Physicians: maximum of 2.25 AMA PRA Category 1 Credits Released: January 13, 2022 Expired: January 12, 2023

Commentary from Dr. Sunil Badve on Ki67 testing for patients with early-stage hormone receptor-positive/HER2-negative breast cancer from the American Society of Clinical Pathology (ASCP) and Clinical Care Options (CCO)

person default Sunil Badve, MD, FRCPath Released: December 28, 2021

Gain key clinical insights quickly with this short slideset from Clinical Care Options (CCO) on CAR T-cell therapy

person default Jesús G. Berdeja, MD Michael R. Bishop, MD Jae H. Park, MD Released: December 20, 2021

Downloadable summary slideset with key data from the 2021 SABCS Symposium from Clinical Care Options (CCO)

Released: December 16, 2021

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings